Open-Label Exploratory, Multiple-Dose Study of Ceftobiprole to Evaluate the Pharmacokinetics and Broncho Alveolar Penetration in Adults With Ventilator-Associated Pneumonia.
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Nosocomial pneumonia
- Focus Pharmacokinetics
- 27 Jul 2012 Company Johnson and Johnson Pharmaceutical added as association as reported by ClinicalTrials.gov record.
- 27 Jul 2012 Actual initiation date changed from Sept 2008 to Oct 2008 as reported by ClinicalTrials.gov record.
- 27 Jul 2012 Actual end date 1 Nov 2009 added as reported by ClinicalTrials.gov record.